<DOC>
	<DOCNO>NCT01980719</DOCNO>
	<brief_summary>The purpose study determine inflammatory marker blood well brain neurotransmitter ( marker in-brain activity metabolism ) relate long-term chronic fatigue .</brief_summary>
	<brief_title>Molecular Determinants Persistent Cancer Related Fatigue</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<criteria>All Participants : Women age 18 old contraindication magnetic resonance imaging ( MRI ) ; Fatigued BC Participants : Have diagnosis breast cancer ; And complete cancerrelated treatment ( i.e. , surgery , chemotherapy , radiotherapy , immunotherapy , etc . ) except hormonal therapy herceptin least 12 week previously ; apparently cancerfree . AgeMatched , Healthy Participants : Generally healthy ; Matched age Â± 2.5 year Fatigued BC participant . No prior history cancer except basal cell squamous cell tumor skin surgically excise ; Have good sleep quality Have chronic pain Have chronic fatigue Pregnant , want become pregnant lactating woman ; Diagnosed anemia [ define hemoglobin level &lt; 12 gm/dl ] receive treatment anemia ; Diagnosed comorbidities likely cause significant fatigue ( i.e. , moderate severe heart failure ) Diagnosed nutritional deficiency ; Have diagnosis untreated hypo hyperthyroidism Have initiation , cessation change dose ( three week prior study 's start ) chronic medication dietary supplement plan change chronic medication dietary supplement study ; Have implant ( e.g. , surgical clip staple ) metal object .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>